Painreform Ownership
| PRFX Stock | USD 2.85 0.31 9.81% |
Shares in Circulation | First Issued 2017-12-31 | Previous Quarter 2 M | Current Value 3.5 M | Avarage Shares Outstanding 2.6 M | Quarterly Volatility 2.4 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Painreform |
Painreform Stock Ownership Analysis
The company has price-to-book ratio of 0.63. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Painreform recorded a loss per share of 147.36. The entity had not issued any dividends in recent years. The firm had 1:6 split on the 9th of September 2024. PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. PainReform Ltd. was incorporated in 2007 and is based in Tel Aviv, Israel. Painreform is traded on NASDAQ Exchange in the United States. To find out more about Painreform contact Ilan MBA at 972 3 7177050 or learn more at https://www.painreform.com.Besides selling stocks to institutional investors, Painreform also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Painreform's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Painreform's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Painreform Quarterly Liabilities And Stockholders Equity |
|
Roughly 3.0% of Painreform are currently held by insiders. Unlike Painreform's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Painreform's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Painreform's insider trades
Painreform Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Painreform is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Painreform backward and forwards among themselves. Painreform's institutional investor refers to the entity that pools money to purchase Painreform's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Ubs Group Ag | 2024-09-30 | 26 K | Virtu Financial Llc | 2024-06-30 | 20.1 K | Two Sigma Securities, Llc | 2024-09-30 | 17.2 K | Hrt Financial Llc | 2024-09-30 | 14.3 K | Advisor Group Holdings, Inc. | 2024-06-30 | 4.6 K | Armistice Capital, Llc | 2024-09-30 | 0.0 |
Painreform Outstanding Bonds
Painreform issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Painreform uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Painreform bonds can be classified according to their maturity, which is the date when Painreform has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Painreform Corporate Filings
6K | 20th of November 2024 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 16th of October 2024 Other Reports | ViewVerify | |
| 20th of September 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Painreform Stock Analysis
When running Painreform's price analysis, check to measure Painreform's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Painreform is operating at the current time. Most of Painreform's value examination focuses on studying past and present price action to predict the probability of Painreform's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Painreform's price. Additionally, you may evaluate how the addition of Painreform to your portfolios can decrease your overall portfolio volatility.